• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?

作者信息

Luchini Claudio, Grant Robert C, Scarpa Aldo, Gallinger Steven

机构信息

Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy.

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

出版信息

Gut. 2021 Oct;70(10):1809-1811. doi: 10.1136/gutjnl-2020-323805. Epub 2021 Jan 19.

DOI:10.1136/gutjnl-2020-323805
PMID:33468535
Abstract
摘要

相似文献

1
Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?胰腺癌中的微卫星不稳定性/错配修复缺陷：相同还是不同？
Gut. 2021 Oct;70(10):1809-1811. doi: 10.1136/gutjnl-2020-323805. Epub 2021 Jan 19.
2
Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards personalized medicine.具有微卫星不稳定性/DNA错配修复缺陷的胰腺导管腺癌。迈向个性化医疗。
Surg Oncol. 2019 Mar;28:121-127. doi: 10.1016/j.suronc.2018.11.019. Epub 2018 Nov 26.
3
Mismatch-repair-deficient metastatic pancreatic ductal adenocarcinoma with a germline PALB2 mutation: unusual genetics, unusual clinical course.具有种系PALB2突变的错配修复缺陷型转移性胰腺导管腺癌：不寻常的遗传学，不寻常的临床病程。
Ann Oncol. 2017 Feb 1;28(2):438-439. doi: 10.1093/annonc/mdw564.
4
Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancer.免疫检查点抑制剂相关糖尿病后错配修复缺陷型胰腺癌的持久缓解。
Immunotherapy. 2021 Oct;13(15):1249-1254. doi: 10.2217/imt-2021-0008. Epub 2021 Aug 2.
5
Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report.免疫检查点抑制剂单药治疗高肿瘤突变负荷复发胰腺导管腺癌患者获得意外良好疗效：1 例报告
Anticancer Drugs. 2022 Oct 1;33(9):975-978. doi: 10.1097/CAD.0000000000001334. Epub 2022 Aug 9.
6
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers.微卫星不稳定性与免疫检查点抑制剂：迈向胃肠道和肝胆癌症的精准医学。
J Gastroenterol. 2020 Jan;55(1):15-26. doi: 10.1007/s00535-019-01620-7. Epub 2019 Sep 7.
7
Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.胰腺导管腺癌中错配修复缺陷的频率。
Pathol Res Pract. 2020 Jun;216(6):152985. doi: 10.1016/j.prp.2020.152985. Epub 2020 Apr 22.
8
Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.林奇综合征患者的胰腺导管内乳头状黏液性肿瘤
World J Gastroenterol. 2015 Mar 7;21(9):2820-5. doi: 10.3748/wjg.v21.i9.2820.
9
Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation.免疫检查点抑制剂治疗短串联重复突变非典型模式的微卫星不稳定阳性胰腺腺癌失败。
Immunotherapy. 2024;16(13):853-858. doi: 10.1080/1750743X.2024.2376516. Epub 2024 Jul 23.
10
Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency.免疫疗法与微卫星不稳定性或错配修复缺陷的转移性结直肠癌
Bull Cancer. 2019 Feb;106(2):137-142. doi: 10.1016/j.bulcan.2018.09.004. Epub 2018 Oct 14.

引用本文的文献

1
Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers.对早发性结外林奇综合征相关癌症患者进行林奇综合征筛查。
Int J Clin Oncol. 2024 Nov;29(11):1696-1703. doi: 10.1007/s10147-024-02609-w. Epub 2024 Aug 26.
2
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors.胃胰肠神经内分泌肿瘤中肿瘤间谱系多样性和免疫抑制转录程序。
Sci Adv. 2023 Sep 29;9(39):eadd9668. doi: 10.1126/sciadv.add9668. Epub 2023 Sep 27.
3
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment.
肝外远端胆管癌与胰腺导管腺癌：用于鉴别诊断和治疗的组织学及分子特征分析
Cancers (Basel). 2023 Feb 24;15(5):1454. doi: 10.3390/cancers15051454.
4
A multicenter comparative study of endoscopic ultrasound-guided fine-needle biopsy using a Franseen needle versus conventional endoscopic ultrasound-guided fine-needle aspiration to evaluate microsatellite instability in patients with unresectable pancreatic cancer.一项多中心比较研究，对比使用 Franseen 针进行内镜超声引导下细针穿刺活检与传统内镜超声引导下细针抽吸，以评估不可切除胰腺癌患者的微卫星不稳定性。
Clin Endosc. 2023 Jan;56(1):107-113. doi: 10.5946/ce.2022.019. Epub 2023 Jan 16.
5
The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.胰腺癌的促纤维增生性基质：异质性的多层水平、临床意义及治疗机会
Cancers (Basel). 2022 Jul 5;14(13):3293. doi: 10.3390/cancers14133293.
6
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer.胰腺癌经典及新型生物标志物的临床应用
Cancers (Basel). 2022 Apr 7;14(8):1866. doi: 10.3390/cancers14081866.
7
Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review.基于肿瘤组织形态学的预测微卫星不稳定性的人工智能：系统评价。
Int J Mol Sci. 2022 Feb 23;23(5):2462. doi: 10.3390/ijms23052462.
8
Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology.胰腺未分化肉瘤样癌：从组织病理学和分子病理学到精准肿瘤学。
Int J Mol Sci. 2022 Jan 24;23(3):1283. doi: 10.3390/ijms23031283.
9
Mismatch repair deficiency in early-onset duodenal, ampullary, and pancreatic carcinomas is a strong indicator for a hereditary defect.早发性十二指肠、壶腹和胰腺腺癌中错配修复缺陷是遗传性缺陷的强烈指标。
J Pathol Clin Res. 2022 Mar;8(2):181-190. doi: 10.1002/cjp2.252. Epub 2021 Dec 6.
10
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions.肿瘤突变负荷作为胰腺癌免疫治疗的潜在生物标志物：系统评价与仍未解决的问题
Cancers (Basel). 2021 Jun 22;13(13):3119. doi: 10.3390/cancers13133119.